hydroxocobalamin b12 injections (B12) Injection, 2mg/mL Hydroxocobalamin 1mg/1ml (5 Vials)

Patients report experiencing relief as if a fog has disappeared

and Demonstrate a substantial clinical improvement, that is, substantially improve the diagnosis or treatment of an illness or injury or improve the functioning of a malformed body part compared to the benefits of a device or devices in a previously established category or other available treatment, or, for devices for which pass-through payment status will begin on or after January 1, 2020, as an alternative pathway to demonstrating substantial clinical improvement, a device is part of the FDA's Breakthrough Devices Program and has received marketing authorization for the indication covered by the Breakthrough Device designation

BPC-157 has been observed to downregulate pro-inflammatory cytokines and protect against NSAID-induced tissue damage, while TB-500 may modulate macrophage activity and support immune cell migration

It does not provide preparation, dosing, oral-use, injection, cycling, stacking or personal-experimentation guidance